Articles citing this article

The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).

Cited article:

Immunogenicity in dogs of three recombinant antigens (TSA, LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis

Vet. Res., 36 5-6 (2005) 827-838
DOI: https://doi.org/10.1051/vetres:2005033

Deletion of MIF gene from live attenuated LdCen−/− parasites enhances protective CD4+ T cell immunity

Jacqueline Araújo Fiuza, Sreenivas Gannavaram, Soraya Torres Gaze, et al.
Scientific Reports 13 (1) (2023)
https://doi.org/10.1038/s41598-023-34333-2

Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges

Eduardo A. F. Coelho and Myron Christodoulides
Vaccines for Neglected Pathogens: Strategies, Achievements and Challenges 281 (2023)
https://doi.org/10.1007/978-3-031-24355-4_13

Live attenuated Leishmania infantum centrin deleted mutant (LiCen) as a novel vaccine candidate: A field study on safety, immunogenicity, and efficacy against canine leishmaniasis

Zabihollah Zarei, Mehdi Mohebali, Hesam Dehghani, Ali Khamesipour, Jalil Tavakkol-Afshari, Behnaz Akhoundi, Mohammad Javad Abbaszadeh-Afshar, Zahra Alizadeh, Seyed Ebrahim Eskandari, Abdolhossein Dalimi Asl and Gholam Reza Razmi
Comparative Immunology, Microbiology and Infectious Diseases 97 101984 (2023)
https://doi.org/10.1016/j.cimid.2023.101984

Live attenuated Leishmania major p27 gene knockout as a novel vaccine candidate: A study on safety, protective immunity and efficacy against canine leishmaniasis caused by Leishmania infantum

S. Elikaee, Z. Zarei, A. Khamesipour, et al.
Acta Tropica 225 106153 (2022)
https://doi.org/10.1016/j.actatropica.2021.106153

Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis

Patrícia A.F. Ribeiro, Danniele L. Vale, Daniel S. Dias, et al.
Cytokine 129 155031 (2020)
https://doi.org/10.1016/j.cyto.2020.155031

Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection

Patrícia A.F. Ribeiro, Daniel S. Dias, Daniela P. Lage, et al.
Molecular Immunology 106 108 (2019)
https://doi.org/10.1016/j.molimm.2018.12.025

The potential HLA Class I-restricted epitopes derived from LeIF and TSA of Leishmania donovani evoke anti-leishmania CD8+ T lymphocyte response

Manas Ranjan Dikhit, Sushmita Das, Vijaya Mahantesh, et al.
Scientific Reports 8 (1) (2018)
https://doi.org/10.1038/s41598-018-32040-x

Therapeutic vaccine of killed Leishmania amazonensis plus saponin reduced parasite burden in dogs naturally infected with Leishmania infantum

Kelvinson Fernandes Viana, Giulia Lacerda, Natália Soares Teixeira, et al.
Veterinary Parasitology 254 98 (2018)
https://doi.org/10.1016/j.vetpar.2018.03.010

Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis

Nahid Maspi, Fatemeh Ghaffarifar, Zohreh Sharifi, Abdolhossein Dalimi and Mohammad Saaid Dayer
APMIS 125 (3) 249 (2017)
https://doi.org/10.1111/apm.12651

Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis

Maria Agallou, Evita Athanasiou, Martina Samiotaki, et al.
PLOS ONE 11 (2) e0149894 (2016)
https://doi.org/10.1371/journal.pone.0149894

Immunogenicity in dogs and protection against visceral leishmaniasis induced by a 14kDa Leishmania infantum recombinant polypeptide

Claudia Abeijon, Nada Daifalla, Greice Krautz-Peterson, et al.
Trials in Vaccinology 5 1 (2016)
https://doi.org/10.1016/j.trivac.2015.11.001

Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis

Mehdi Shahbazi, Farnaz Zahedifard, Noushin Saljoughian, et al.
Veterinary Parasitology 212 (3-4) 130 (2015)
https://doi.org/10.1016/j.vetpar.2015.07.005

Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis

Pranati Das, Ajay Amit, Shubhankar Kumar Singh, et al.
Parasitology International 64 (1) 18 (2015)
https://doi.org/10.1016/j.parint.2014.08.004

Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum

Jacqueline Araújo Fiuza, Sreenivas Gannavaram, Helton da Costa Santiago, et al.
Vaccine 33 (2) 280 (2015)
https://doi.org/10.1016/j.vaccine.2014.11.039

Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis

Mehdi Shahbazi, Farnaz Zahedifard, Tahereh Taheri, et al.
PLOS ONE 10 (7) e0132794 (2015)
https://doi.org/10.1371/journal.pone.0132794

Evaluation of the immunogenicity and protective efficacy of Killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis

Ankita Thakur, Harpreet Kaur and Sukhbir Kaur
Medical Microbiology and Immunology 204 (4) 539 (2015)
https://doi.org/10.1007/s00430-014-0367-9

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins

Maria Agallou, Evita Athanasiou, Olga Koutsoni, Eleni Dotsika and Evdokia Karagouni
Frontiers in Immunology 5 (2014)
https://doi.org/10.3389/fimmu.2014.00268

LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4+ and CD8+) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis

Rodrigo Dian de Oliveira Aguiar-Soares, Bruno Mendes Roatt, Henrique Gama Ker, et al.
Parasites & Vectors 7 (1) (2014)
https://doi.org/10.1186/1756-3305-7-61

Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs

Jacqueline Araújo Fiuza, Helton da Costa Santiago, Angamuthu Selvapandiyan, et al.
Vaccine 31 (14) 1785 (2013)
https://doi.org/10.1016/j.vaccine.2013.01.048

Leishmaniasis: recombinant DNA vaccination and different approaches for vaccine development

Tahereh Taheri and Sima Rafati
Clinical Investigation 3 (11) 1023 (2013)
https://doi.org/10.4155/cli.13.99

Risk Factors for Seroconversion by Leishmania infantum in a Cohort of Dogs from an Endemic Area of Brazil

Wendel Coura-Vital, Alexandre Barbosa Reis, Maria Arlene Fausto, et al.
PLoS ONE 8 (8) e71833 (2013)
https://doi.org/10.1371/journal.pone.0071833

Micro/nanoparticle adjuvants for antileishmanial vaccines: Present and future trends

Ali Badiee, Vahid Heravi Shargh, Ali Khamesipour and Mahmoud Reza Jaafari
Vaccine 31 (5) 735 (2013)
https://doi.org/10.1016/j.vaccine.2012.11.068

Performance of LBSap Vaccine after Intradermal Challenge with L. infantum and Saliva of Lu. longipalpis: Immunogenicity and Parasitological Evaluation

Bruno Mendes Roatt, Rodrigo Dian de Oliveira Aguiar-Soares, Juliana Vitoriano-Souza, et al.
PLoS ONE 7 (11) e49780 (2012)
https://doi.org/10.1371/journal.pone.0049780

Identification of Leishmania infantum chagasi proteins in urine of patients with visceral leishmaniasis: a promising antigen discovery approach of vaccine candidates

S. S. KASHINO, C. ABEIJON, L. QIN, K. A. KANUNFRE, F. S. KUBRUSLY, F. O. SILVA, D. L. COSTA, D. CAMPOS, C. H. N. COSTA, I. RAW and A. CAMPOS‐NETO
Parasite Immunology 34 (7) 360 (2012)
https://doi.org/10.1111/j.1365-3024.2012.01365.x

Efficacy of Leishmania donovani ribosomal P1 gene as DNA vaccine in experimental visceral leishmaniasis

Shet Masih, Sunil K. Arora and Rakesh K. Vasishta
Experimental Parasitology 129 (1) 55 (2011)
https://doi.org/10.1016/j.exppara.2011.05.014

Methods of Control of theLeishmania infantumDog Reservoir: State of the Art

Michele Podaliri Vulpiani, Luigi Iannetti, Daniela Paganico, Filomena Iannino and Nicola Ferri
Veterinary Medicine International 2011 1 (2011)
https://doi.org/10.4061/2011/215964

An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens

Márcia Cristina Aquino Teixeira, Geraldo Gileno de Sá Oliveira, Patrícia Oliveira Meira Santos, et al.
Memórias do Instituto Oswaldo Cruz 106 (2) 182 (2011)
https://doi.org/10.1590/S0074-02762011000200011

Humoral and In Vivo Cellular Immunity against the Raw Insect-Derived Recombinant Leishmania infantum Antigens KMPII, TRYP, LACK, and papLe22 in Dogs from an Endemic Area

Felicitat Todolí, José M. Escribano, Rafael de Juan, et al.
The American Journal of Tropical Medicine and Hygiene 83 (6) 1287 (2010)
https://doi.org/10.4269/ajtmh.2010.09-0784

Comparison between three adjuvants for a vaccine against canine leishmaniasis: In vitro evaluation of macrophage killing ability

T. Trotta, A. Fasanella, D. Scaltrito, et al.
Comparative Immunology, Microbiology and Infectious Diseases 33 (2) 175 (2010)
https://doi.org/10.1016/j.cimid.2009.12.003

Immunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis

G.P. Borja-Cabrera, F.N. Santos, F.B. Santos, et al.
Vaccine 28 (3) 597 (2010)
https://doi.org/10.1016/j.vaccine.2009.09.071

Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis

Alexandre B. Reis, Rodolfo C. Giunchetti, Eugenia Carrillo, Olindo A. Martins-Filho and Javier Moreno
Trends in Parasitology 26 (7) 341 (2010)
https://doi.org/10.1016/j.pt.2010.04.005

The Chimerical Multi-Component Q protein from Leishmania in the absence of adjuvant protects dogs against an experimental Leishmania infantum infection

J. Carcelén, V. Iniesta, J. Fernández-Cotrina, et al.
Vaccine 27 (43) 5964 (2009)
https://doi.org/10.1016/j.vaccine.2009.07.069

A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis

Connor Carson, Maria Antoniou, Maria Begoña Ruiz-Argüello, et al.
Vaccine 27 (7) 1080 (2009)
https://doi.org/10.1016/j.vaccine.2008.11.094

Immunopathology of natural infection with Trypanosoma cruzi in dogs

Julio Vladimir Cruz-Chan, Manuel Bolio-González, Rafael Colín-Flores, et al.
Veterinary Parasitology 162 (1-2) 151 (2009)
https://doi.org/10.1016/j.vetpar.2009.02.024

Seroreactivity against raw insect-derived recombinant KMPII, TRYP, and LACK Leishmania infantum proteins in infected dogs

Felicitat Todolí, Mariano Pérez-Filgueira, Inmaculada Galindo, et al.
Veterinary Parasitology 164 (2-4) 154 (2009)
https://doi.org/10.1016/j.vetpar.2009.05.032

Searching Genes Encoding Leishmania Antigens for Diagnosis and Protection

Manuel Soto, Laura Ramírez, Miguel A. Pineda, et al.
Scholarly Research Exchange 2009 1 (2009)
https://doi.org/10.3814/2009/173039

IgG subclass profile of serum antibodies to Leishmania chagasi in naturally infected and vaccinated dogs

Trícia M.F.S. Oliveira, Tiago W.P. Mineo, Melina Bason, Michael J. Day and Rosangela Z. Machado
Veterinary Parasitology 162 (1-2) 16 (2009)
https://doi.org/10.1016/j.vetpar.2009.02.018

T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune®

Márcio Sobreira Silva Araújo, Renata Aline de Andrade, Renato Sathler-Avelar, et al.
Vaccine 27 (7) 1008 (2009)
https://doi.org/10.1016/j.vaccine.2008.11.104

Antigenicity of a whole parasite vaccine as promising candidate against canine leishmaniasis

Rodolfo Cordeiro Giunchetti, Alexandre Barbosa Reis, Denise da Silveira-Lemos, et al.
Research in Veterinary Science 85 (1) 106 (2008)
https://doi.org/10.1016/j.rvsc.2007.09.008

Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis

Eugenia Carrillo, Martín Crusat, Javier Nieto, et al.
Vaccine 26 (15) 1902 (2008)
https://doi.org/10.1016/j.vaccine.2008.01.042

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f®+MPL-SE® vaccine to treat canine visceral leishmaniasis

Jorge Miret, Evaldo Nascimento, Weverton Sampaio, et al.
Vaccine 26 (12) 1585 (2008)
https://doi.org/10.1016/j.vaccine.2008.01.026

FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine

Clarisa B Palatnik-de-Sousa, André de Figueiredo Barbosa, Sandra Maria Oliveira, et al.
Expert Review of Vaccines 7 (6) 833 (2008)
https://doi.org/10.1586/14760584.7.6.833

Visceral leishmaniasis in large Brazilian cities: challenges for control

Claudia Di Lorenzo Oliveira, Maria Helena Franco Morais and George Luiz Lins Machado-Coelho
Cadernos de Saúde Pública 24 (12) 2953 (2008)
https://doi.org/10.1590/S0102-311X2008001200026

Immunogenicity of a killed Leishmania vaccine with saponin adjuvant in dogs

Rodolfo Cordeiro Giunchetti, Rodrigo Corrêa-Oliveira, Olindo Assis Martins-Filho, et al.
Vaccine 25 (44) 7674 (2007)
https://doi.org/10.1016/j.vaccine.2007.08.009

Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis

J. Moreno, J. Nieto, S. Masina, et al.
Vaccine 25 (29) 5290 (2007)
https://doi.org/10.1016/j.vaccine.2007.05.010

Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge

Alhelí Rodríguez-Cortés, Ana Ojeda, Laura López-Fuertes, et al.
Vaccine 25 (46) 7962 (2007)
https://doi.org/10.1016/j.vaccine.2007.08.023

Leishmania major: Immune response in BALB/c mice immunized with stress-inducible protein 1 encapsulated in liposomes

Ali Badiee, Mahmoud R. Jaafari and Ali Khamesipour
Experimental Parasitology 115 (2) 127 (2007)
https://doi.org/10.1016/j.exppara.2006.07.002

Interleukin-6 has differential influence on the ability of adjuvant formulations to potentiate antibody reponses to a Plasmodium falciparum blood-stage vaccine

George Hui and Caryn Hashimoto
Vaccine 25 (36) 6598 (2007)
https://doi.org/10.1016/j.vaccine.2007.06.057

Current understandings on the immunology of leishmaniasis and recent developments in prevention and treatment

M. T. M. Roberts
British Medical Bulletin 75-76 (1) 115 (2005)
https://doi.org/10.1093/bmb/ldl003